The United Nations Framework Convention on Climate Change includes a Gender Action Plan, adopted in 2017. The plan aims to ...
Key Business Updates BRUKINSA ® (zanubrutinib) is an orally available, small molecule inhibitor of BTK designed to deliver ...
Graduate student Dina Rogers won the prestigious Falling Walls global competition in Berlin, Germany last week for her pitch ...
KinCon biolabs now uses its technology to predict and this in living cells, whether drug candidates effectively bind to ...
University of California, Riverside scientists have designed novel agents that bind to and degrade Pin1, a protein linked to ...
In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins.
KinCon biolabs, a spin-off from the University of Innsbruck, is expanding its patented platform technology to support ...
A team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer development. In drug discovery, targeted protein degradation is a ...
Richard F. Ludueña, Professor Emeritus at the University of Texas Health San Antonio, discusses his innovative approach to ...